Suven Life Sciences Gets Product Patents in Eurasia

Suven Life Sciences Ltd. has announced that two product patents were granted in Eurasia (009193 and 009367) for two of their new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases and these patents are valid until 2023.
Pharmabiz.com